$IPAR
INTERPARFUMS INC

2023 Q2 Form 10-Q Financial Statement

#000175392623000594 Filed on May 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $309.2M $311.7M $250.7M
YoY Change 26.36% 24.35% 26.29%
Cost Of Revenue $120.8M $108.8M $111.4M
YoY Change 10.01% -2.38% 25.61%
Gross Profit $188.4M $203.0M $139.3M
YoY Change 39.68% 45.74% 26.83%
Gross Profit Margin 60.92% 65.11% 55.55%
Selling, General & Admin $133.4M $112.7M $78.04M
YoY Change 49.06% 44.38% 31.16%
% of Gross Profit 70.8% 55.52% 56.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.252M $4.115M $3.124M
YoY Change 15.57% 31.72% 23.48%
% of Gross Profit 2.26% 2.03% 2.24%
Operating Expenses $133.4M $112.7M $78.04M
YoY Change 49.06% 44.38% 31.16%
Operating Profit $55.02M $90.28M $61.22M
YoY Change 21.2% 47.47% 21.7%
Interest Expense $2.276M $2.357M -$110.0K
YoY Change -912.86% -2242.73% -105.79%
% of Operating Profit 4.14% 2.61% -0.18%
Other Income/Expense, Net $454.0K $2.307M $116.0K
YoY Change 38.41% 1888.79% -42.0%
Pretax Income $55.48M $92.59M $61.22M
YoY Change 22.07% 51.23% 22.45%
Income Tax $12.96M $21.68M $14.93M
% Of Pretax Income 23.36% 23.41% 24.39%
Net Earnings $34.95M $54.07M $35.30M
YoY Change 26.56% 53.17% 27.43%
Net Earnings / Revenue 11.3% 17.34% 14.08%
Basic Earnings Per Share $1.09 $1.69 $1.11
Diluted Earnings Per Share $1.09 $1.68 $1.103M
COMMON SHARES
Basic Shares Outstanding 32.01M shares 32.11M shares 31.84K shares
Diluted Shares Outstanding 32.16K shares 32.16K shares 32.01K shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $186.8M $237.8M $265.2M
YoY Change -4.65% -10.36% -9.75%
Cash & Equivalents $74.31M $149.1M $110.1M
Short-Term Investments $112.4M $88.70M $155.1M
Other Short-Term Assets $24.99M $20.35M $23.16M
YoY Change 36.54% -12.15% 24.52%
Inventory $360.0M $323.7M $227.1M
Prepaid Expenses
Receivables $236.6M $241.9M $206.3M
Other Receivables $14.73M $27.78M $12.70M
Total Short-Term Assets $823.4M $851.6M $734.5M
YoY Change 21.05% 15.95% 19.8%
LONG-TERM ASSETS
Property, Plant & Equipment $168.3M $169.0M $189.2M
YoY Change -12.47% -10.68% 353.81%
Goodwill
YoY Change
Intangibles $292.3M $294.3M
YoY Change
Long-Term Investments
YoY Change
Other Assets $25.30M $25.83M $29.54M
YoY Change -25.09% -12.58% -3.77%
Total Long-Term Assets $528.2M $528.6M $427.7M
YoY Change 25.1% 23.58% 55.77%
TOTAL ASSETS
Total Short-Term Assets $823.4M $851.6M $734.5M
Total Long-Term Assets $528.2M $528.6M $427.7M
Total Assets $1.352B $1.380B $1.162B
YoY Change 22.61% 18.76% 30.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $91.04M $93.05M $72.57M
YoY Change 9.15% 28.23% 62.34%
Accrued Expenses $194.0M $190.3M $149.4M
YoY Change 52.89% 27.41% 59.58%
Deferred Revenue
YoY Change
Short-Term Debt $4.958M $18.00M $0.00
YoY Change
Long-Term Debt Due $29.08M $29.09M $14.38M
YoY Change 117.96% 102.35% 1207.0%
Total Short-Term Liabilities $341.7M $362.2M $250.2M
YoY Change 45.09% 44.74% 64.52%
LONG-TERM LIABILITIES
Long-Term Debt $138.6M $145.1M $125.2M
YoY Change 18.07% 15.95% 1260.48%
Other Long-Term Liabilities $24.49M $23.30M $28.57M
YoY Change -7.91% -18.45% 44.31%
Total Long-Term Liabilities $138.6M $145.1M $153.7M
YoY Change -3.74% -5.6% 430.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $341.7M $362.2M $250.2M
Total Long-Term Liabilities $138.6M $145.1M $153.7M
Total Liabilities $480.2M $507.3M $577.6M
YoY Change -9.84% -12.18% 66.18%
SHAREHOLDERS EQUITY
Retained Earnings $669.7M $654.4M
YoY Change
Common Stock $32.00K $32.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $48.76M $43.06M
YoY Change
Treasury Stock Shares
Shareholders Equity $668.2M $658.4M $584.6M
YoY Change
Total Liabilities & Shareholders Equity $1.352B $1.380B $1.162B
YoY Change 22.61% 18.76% 30.92%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $34.95M $54.07M $35.30M
YoY Change 26.56% 53.17% 27.43%
Depreciation, Depletion And Amortization $4.252M $4.115M $3.124M
YoY Change 15.57% 31.72% 23.48%
Cash From Operating Activities $14.12M -$7.358M -$23.94M
YoY Change -409.44% -69.27% -173.63%
INVESTING ACTIVITIES
Capital Expenditures $864.0K $2.415M -$13.54M
YoY Change -104.86% -117.83% 796.82%
Acquisitions
YoY Change
Other Investing Activities -$23.23M $64.21M $1.739M
YoY Change -1617.18% 3592.35% -105.73%
Cash From Investing Activities -$24.09M $61.64M -$11.80M
YoY Change 48.28% -622.27% -62.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $9.397M $4.379M
YoY Change 114.59%
Cash From Financing Activities -64.88M -$12.56M -20.03M
YoY Change 66.42% -37.33% -3.55%
NET CHANGE
Cash From Operating Activities 14.12M -$7.358M -23.94M
Cash From Investing Activities -24.09M $61.64M -11.80M
Cash From Financing Activities -64.88M -$12.56M -20.03M
Net Change In Cash -74.84M $44.34M -55.78M
YoY Change 25.17% -179.5% 177.23%
FREE CASH FLOW
Cash From Operating Activities $14.12M -$7.358M -$23.94M
Capital Expenditures $864.0K $2.415M -$13.54M
Free Cash Flow $13.26M -$9.773M -$10.40M
YoY Change 0.33% -6.05% -130.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
20346000 usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000822663
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
27779000 usd
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
usd
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
usd
CY2022Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
usd
CY2023Q1 us-gaap Long Term Debt Term
LongTermDebtTerm
P10Y
CY2022Q4 us-gaap Long Term Debt Term
LongTermDebtTerm
P4Y
CY2021Q2 us-gaap Long Term Debt Term
LongTermDebtTerm
P10Y
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M0D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y6M21D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y9M0D
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
0-16469
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
INTER PARFUMS, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3275609
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
551 Fifth Avenue
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10176
CY2023Q1 dei City Area Code
CityAreaCode
212
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
983-2640
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $.001 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
IPAR
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32012950 shares
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
149055000 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
104713000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
88702000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
150833000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
241948000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
197584000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
323700000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
289984000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
28803000 usd
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32012950 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31967300 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
32000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
15650000 usd
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
71000 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
157000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
851601000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
787724000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
169036000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
166722000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26901000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27964000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
294300000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
290853000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12543000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11159000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
25825000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24120000 usd
CY2023Q1 us-gaap Assets
Assets
1380206000 usd
CY2022Q4 us-gaap Assets
Assets
1308542000 usd
CY2023Q1 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
18000000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
29092000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
28547000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5310000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5296000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
93053000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
88388000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
190305000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
213621000 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
26409000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
8715000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
362169000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
344567000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
145128000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
151494000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23302000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24335000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
32000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
95429000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
35299000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.69
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90186000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
654440000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
620095000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-48440000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-56056000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
9907865 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
9864805 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
43055000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
37475000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
658406000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
616782000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
191201000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
171364000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
849607000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
788146000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1380206000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1308542000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
311723000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
250678000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
108766000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
92020000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
202957000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
158658000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
112678000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
97441000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
90279000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
61217000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
2357000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
883000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-759000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2239000 usd
CY2023Q1 ipar Investment Income Interest And Dividend1
InvestmentIncomeInterestAndDividend1
5382000 usd
CY2022Q1 ipar Investment Income Interest And Dividend1
InvestmentIncomeInterestAndDividend1
-1466000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
41000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
116000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2307000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
92586000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
61223000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21678000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14932000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
70908000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
46291000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
16840000 usd
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
10992000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54068000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
1324000 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
1881000 usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.68
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.10
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32018 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31840 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32159 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32010 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.625
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2023Q1 us-gaap Profit Loss
ProfitLoss
70908000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
46291000 usd
CY2023Q1 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest
4166000 usd
CY2022Q1 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest
-261000 usd
CY2023Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-1709000 usd
CY2022Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-992000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13489000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12441000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
81940000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
35103000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
16840000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
10992000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-206000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
72000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-3622000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
3419000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
20256000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
7645000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
61684000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27458000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
788146000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
738332000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
70908000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
46291000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
849607000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
758241000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
70908000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
46291000 usd
CY2023Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
4115000 usd
CY2022Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3124000 usd
CY2023Q1 ipar Provision For Doubtful Accounts1
ProvisionForDoubtfulAccounts1
220000 usd
CY2022Q1 ipar Provision For Doubtful Accounts1
ProvisionForDoubtfulAccounts1
1048000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
633000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
654000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
41000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
116000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1188000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
135000 usd
CY2023Q1 ipar Change In Fair Value Of Derivatives
ChangeInFairValueOfDerivatives
-1518000 usd
CY2022Q1 ipar Change In Fair Value Of Derivatives
ChangeInFairValueOfDerivatives
3803000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
42670000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
50316000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
29688000 usd
CY2022Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
54400000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31195000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5640000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2869000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1293000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1671000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-23327000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3203000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
17771000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
9690000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7358000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23944000 usd
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
42835000 usd
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2243000 usd
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
107045000 usd
CY2022Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
3982000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2415000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12895000 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
151000 usd
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
647000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
61644000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11803000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
17989000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
9397000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4379000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4929000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
708000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
20023000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15921000 usd
CY2023Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
473000 usd
CY2022Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
440000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
5580000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12555000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20032000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2611000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2486000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
44342000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-58265000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104713000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168387000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
149055000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110122000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1563000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
797000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
4816000 usd
CY2022Q4 us-gaap Derivative Swaption Interest Rate
DerivativeSwaptionInterestRate
0.02 pure
CY2021Q2 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
130500000 usd
CY2023Q1 us-gaap Derivative Swaption Interest Rate
DerivativeSwaptionInterestRate
0.011 pure
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
5193000 usd
CY2021Q2 us-gaap Minority Interest Ownership Percentage By Parent
MinorityInterestOwnershipPercentageByParent
0.72 pure
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
151000000 usd
CY2023Q1 us-gaap Acquisition Costs
AcquisitionCosts
4500000 usd
CY2023Q1 us-gaap Escrow Deposit
EscrowDeposit
1800000 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
120000000
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
130500000 usd
CY2023Q1 us-gaap Debt Instrument Interest Rate Terms
DebtInstrumentInterestRateTerms
one-month Euribor plus 0.75%
CY2023Q1 us-gaap Derivative Variable Interest Rate
DerivativeVariableInterestRate
0.02 pure
CY2023Q1 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.011 pure
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
155013000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
146772000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
168687000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
143212000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
323700000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
289984000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.026 pure
CY2023Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1400000 usd
CY2022Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1800000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1300000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1700000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
0 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
0 usd
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
168730 shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
16.31
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
23080 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
13.58
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
145650 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
16.74
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
630000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
650000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Other Share Increase Decrease
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease
430000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Other Share Increase Decrease
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease
440000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
441580 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
67.30
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
15480 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
70.48
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
88710 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
55.57
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
337390 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
70.24
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
191740 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
61.38
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
574455 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
24300000 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
15500000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2400000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4929000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
708000 usd
CY2023Q1 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
780000 usd
CY2022Q1 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
75000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5403000 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
635000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Splits
StockIssuedDuringPeriodSharesStockSplits
211955 shares
CY2022Q2 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
4800000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54068000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
35299000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32018 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31840 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
141 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
170 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32159 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32010 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.69
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.68
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.10
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
311723000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
250678000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54068000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
35299000 usd
CY2023Q1 us-gaap Assets
Assets
1380206000 usd
CY2022Q4 us-gaap Assets
Assets
1308542000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001753926-23-000594-index-headers.html Edgar Link pending
0001753926-23-000594-index.html Edgar Link pending
0001753926-23-000594.txt Edgar Link pending
0001753926-23-000594-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g083513_10q.htm Edgar Link pending
g083513_ex31-1.htm Edgar Link pending
g083513_ex31-2.htm Edgar Link pending
g083513_ex32-1.htm Edgar Link pending
g083513_ex32-2.htm Edgar Link pending
ipar-20230331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ipar-20230331_cal.xml Edgar Link unprocessable
ipar-20230331_def.xml Edgar Link unprocessable
ipar-20230331_lab.xml Edgar Link unprocessable
ipar-20230331_pre.xml Edgar Link unprocessable
g083513_10q_htm.xml Edgar Link completed